An Artificial Intelligence Model Using Diffusion Basis Spectrum Imaging Metrics Accurately Predicts Clinically Significant Prostate Cancer.

Journal: The Journal of urology
PMID:

Abstract

PURPOSE: Conventional prostate magnetic resonance imaging has limited accuracy for clinically significant prostate cancer (csPCa). We performed diffusion basis spectrum imaging (DBSI) before biopsy and applied artificial intelligence models to these DBSI metrics to predict csPCa.

Authors

  • Eric H Kim
    Division of Urology, Department of Surgery, Washington University School of Medicine, St. Louis, Missouri.
  • Huaping Jing
    Mallinckrodt Institute of Radiology, Washington University School of Medicine, St Louis, Missouri.
  • Kainen L Utt
    Mallinckrodt Institute of Radiology, Washington University School of Medicine, St Louis, Missouri.
  • Joel M Vetter
    School of Medicine, Washington University in St. Louis, St. Louis, Missouri, USA.
  • R Cody Weimholt
    Department of Pathology, Washington University School of Medicine, St Louis, Missouri.
  • Arnold D Bullock
    Division of Urology, Department of Surgery, Washington University School of Medicine, St Louis, Missouri.
  • Alexandra P Klim
    Division of Urology, Department of Surgery, Washington University School of Medicine, St Louis, Missouri.
  • Karla A Bergeron
    Division of Urology, Department of Surgery, Washington University School of Medicine, St Louis, Missouri.
  • Jason K Frankel
    Kaiser Permanente, The Permanente Medical Group, Walnut Creek, California.
  • Zachary L Smith
    Division of Urologic Surgery, Washington University School of Medicine, 4960 Children's Place, Campus Box 8242, St. Louis, MO, 63110, USA.
  • Gerald L Andriole
    Prostatype Genomics, Solna, Sweden.
  • Sheng-Kwei Song
    Department of Radiology, Washington University School of Medicine, St. Louis, Missouri, 63110.
  • Joseph E Ippolito
    Washington University School of Medicine, 660 S Euclid Ave, Campus, Box 8131, St Louis, MO, 63110, USA.